30 Questions
What is the first objective mentioned in the text?
Define overweight and obesity.
Which guideline is mentioned as a clinical resource in the text?
ACC/AHA/TOS Overweight and Obesity Guidelines
What is the recommended resource for review in the text?
Sheehan A, Chen JT, Yanovski JA. Obesity. In: DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod VL, Posey L. eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 12th Edition
What is the date of access for the CDC's New Adult Obesity Maps?
October 25, 2021
What is the overarching goal of the text?
To provide clinical guidelines for obesity management
What is the primary focus of the Objectives mentioned in the text?
Lifestyle therapy for weight management
What is the recommended website for dietary guidance mentioned in the text?
MyPlate from US Dept of Agriculture: myplate.gov
When should pharmacotherapy for weight loss be initiated according to the text?
After lifestyle therapy has been unsuccessful
What is the primary focus of the Clinical Guidelines mentioned in the text?
Pharmacological management of obesity
What is the purpose of calculating a patient’s body mass index (BMI) as mentioned in the text?
To classify weight status and assess health risks
Which factor is NOT mentioned as a contributor to obesity?
Psychological factors
What is the recommended duration for moderate to vigorous activity most days per week for promoting weight loss and cardiometabolic health?
30-60 minutes
Which of the following is a criterion for Metabolic Syndrome associated with obesity?
Elevated blood glucose
What is the main tool used to classify obesity?
Body Mass Index (BMI)
Which of the following is NOT recommended for nutrition in the management of obesity?
Consuming saturated fats
What is the general weight loss goal through diet and exercise in 6-12 months?
5-10%
Which medication is NOT mentioned as a potential cause of drug-induced weight gain?
Antibiotics
What is the overall goal for exercise in promoting weight loss and cardiometabolic health?
30-60 minutes most days per week
What does obesity increase the risk of, along with an increased risk of morbidity from chronic diseases such as diabetes and cardiovascular diseases?
All-cause mortality and cardiovascular mortality
What is the main driving factor contributing to obesity according to the text?
Caloric intake exceeding caloric expenditure
Which medication may lead to increased heart rate, dry mouth, and constipation?
Phentermine/topiramate ER
What adverse effects are commonly associated with GLP-1 receptor agonists?
Nausea/vomiting and increased risk of pancreatitis and gallbladder disease
What are common adverse effects of naltrexone/bupropion?
Nausea/vomiting, headache, and increased heart rate/blood pressure
What is a common adverse effect of orlistat?
Abdominal pain, flatulence, and fecal urgency or incontinence
What is a key focus of behavioral therapy for obesity management?
Behavior modification, goal setting, and self-monitoring
What is the efficacy goal for pharmacotherapy in obesity management at 3 months?
≥5% weight loss
What BMI criteria are considered for bariatric surgery?
≥40 kg/m2 or ≥35 kg/m2 with obesity-related comorbidities
What type of bariatric surgery involves vertical-banded gastroplasty?
Vertical-banded gastroplasty
What are potential complications of bariatric surgery?
Surgical complications, nutrient deficiencies, and changes in drug absorption
What is a requirement for candidates for bariatric surgery?
Motivated to lose weight and have insufficient weight loss with behavioral therapy ± pharmacotherapy
Study Notes
Obesity Management Interventions: Behavioral Therapy, Pharmacotherapy, and Bariatric Surgery
- Behavioral therapy involves a comprehensive lifestyle program focusing on behavior modification, goal setting, and self-monitoring
- Pharmacotherapy includes the use of medications such as sympathomimetic agents, GLP-1 receptor agonists, phentermine/topiramate ER, naltrexone/bupropion, and orlistat
- Sympathomimetic agents like phentermine have common adverse effects including increased blood pressure/heart rate and constipation
- GLP-1 receptor agonists like liraglutide and semaglutide can cause nausea/vomiting and increased risk of pancreatitis and gallbladder disease
- Phentermine/topiramate ER may lead to increased heart rate/blood pressure, dry mouth, and constipation
- Naltrexone/bupropion can cause nausea/vomiting, headache, and increased heart rate/blood pressure
- Orlistat may result in common adverse effects like abdominal pain, flatulence, and fecal urgency or incontinence
- Monitoring factors for pharmacotherapy include efficacy goal of ≥5% weight loss at 3 months and safety/tolerability assessments
- Bariatric surgery is considered for individuals with a BMI ≥40 kg/m2 or ≥35 kg/m2 with obesity-related comorbidities
- Bariatric surgery can lead to surgical complications, nutrient deficiencies, and changes in drug absorption
- Types of bariatric surgery include vertical-banded gastroplasty, adjustable gastric banding, and Roux-en-Y gastric bypass
- Candidates for bariatric surgery should be motivated to lose weight and have insufficient weight loss with behavioral therapy ± pharmacotherapy
Test your knowledge of obesity management interventions including behavioral therapy, pharmacotherapy, and bariatric surgery. Explore the common adverse effects of sympathomimetic agents, GLP-1 receptor agonists, and other medications, as well as the monitoring factors for pharmacotherapy. Learn about the criteria and types of bariatric surgery, and the potential complications and considerations for candidates.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
